The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
while many researchers believe that exposure to humans to relatively low levels in the diet will not result in clinical neuropathy some neurotoxicologists are concerned about the potential for its cumulative neurotoxicity it has been shown in several studies that the same neurotoxic effects can be observed at low and high doses for acrylamide with the low doses simply requiring longer exposures
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.